SS Innovations International, Inc. (SSII)
3.50
-0.08
(-2.37%)
USD |
NASDAQ |
Aug 24, 16:00
3.57
+0.07
(+2.00%)
Pre-Market: 08:09
SS Innovations International Gross Profit Margin (Quarterly) : 48.40% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 48.40% |
| March 31, 2026 | 44.99% |
| December 31, 2025 | 41.71% |
| September 30, 2025 | 45.63% |
| June 30, 2025 | 56.47% |
| March 31, 2025 | 16.85% |
| December 31, 2024 | 46.99% |
| September 30, 2024 | 12.81% |
| Date | Value |
|---|---|
| June 30, 2024 | 16.83% |
| March 31, 2024 | 17.48% |
| December 31, 2023 | -12.49% |
| September 30, 2023 | -1.33% |
| June 30, 2023 | -5.36% |
| March 31, 2023 | 12.27% |
| December 31, 2022 | |
| September 30, 2022 | 40.78% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Microbot Medical, Inc. | -273.0% |
| Vicarious Surgical, Inc. | -- |
| Accuray, Inc. | 34.76% |
| Orthofix Medical, Inc. | 69.55% |
| ResMed, Inc. | 58.12% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -27.29% |
| Return on Assets | -15.48% |
| Return on Invested Capital | -20.98% |
| Profit Margin (Quarterly) | -19.11% |
| Operating Margin (Quarterly) | -16.43% |
| Return on Net Operating Assets | -29.67% |